Type2 Diabetes Mellitus

Metabolic Diseases
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

DS
Daiichi SankyoChina - Shanghai
1 program
DS-8500aN/A1 trial
Active Trials
NCT02628392Completed368Est. Sep 2016
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Exposure to Anti-thrombotic treatment agents and glucose lowering therapyN/A1 trial
Active Trials
NCT04481997Completed1,000Est. Jan 2024
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino CommunityN/A1 trial
Active Trials
NCT03736486Completed100Est. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaExposure to Anti-thrombotic treatment agents and glucose lowering therapy
Eli Lilly and CompanyMil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community
Daiichi SankyoDS-8500a

Clinical Trials (3)

Total enrollment: 1,468 patients across 3 trials

NCT04481997AstraZenecaExposure to Anti-thrombotic treatment agents and glucose lowering therapy

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

Start: Jan 2021Est. completion: Jan 20241,000 patients
N/ACompleted
NCT03736486Eli Lilly and CompanyMil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community

Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community

Start: Aug 2017Est. completion: Dec 2018100 patients
N/ACompleted
NCT02628392Daiichi SankyoDS-8500a

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Start: Nov 2015Est. completion: Sep 2016368 patients
N/ACompleted

Related Jobs in Metabolic Diseases

Manager, Patient Safety and Pharmacovigilance Operations

Kailera Therapeutics
Waltham, Massachusetts
9h ago

Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV

Amgen
California - San Francisco, US
Yesterday

(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)

Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago

Computational Chemist

Topos Bio
San Francisco Office
2d ago

Associate Director, Legal Operations & Contracts Management

Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr

Application & Integration Architect

Roche
Indianapolis
5d ago
$106K - $196K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Diabetes(737)Diabetes Mellitus, Type 2(485)Obesity(246)Type 2 Diabetes(207)Type 2 Diabetes Mellitus(190)Diabetes Mellitus(127)Diabetes Mellitus, Type 1(95)Type 1 Diabetes Mellitus(51)Type 1 Diabetes(50)Dyslipidemia(45)